Impax Asset Management Group PLC Abbott Laboratories Transaction History

Impax Asset Management Group PLC

$23 Billion
Q3 2024

A detailed history of Impax Asset Management Group PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Impax Asset Management Group PLC holds 557,608 shares of ABT stock, worth $64.6 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

557,608

Previous 557,608 -0.0%

Holding current value

$64.6 Million

Previous $63.6 Million -0.0%

% of portfolio

0.28%

Previous 0.28%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$100.07 - $118.13 $275,592 - $325,330	2,754 Added 0.5%	557,608 $63.6 Million
Q2 2024 Nov 08, 2024	SELL	$100.73 - $112.44 $277,410 - $309,659	-2,754 Reduced 0.49%	554,854 $57.7 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $12.2 Million - $13.6 Million	-121,228 Reduced 17.93%	554,854 $57.7 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $21.9 Million - $24.2 Million	-200,169 Reduced 22.84%	676,082 $76.8 Million
Q4 2023 Jan 26, 2024	BUY	$90.19 - $110.4 $7.5 Million - $9.18 Million	83,175 Added 10.49%	876,251 $96.4 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $30.1 Million - $36.1 Million	314,819 Added 65.83%	793,076 $76.8 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $43.7 Million - $48.7 Million	433,930 Added 978.93%	478,257 $52.1 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $192,073 - $226,081	1,983 Added 4.68%	44,327 $4.49 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $1.53 Million - $1.8 Million	-16,142 Reduced 27.6%	42,344 $4.65 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $125,788 - $145,639	-1,300 Reduced 2.17%	58,486 $5.66 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $326,419 - $394,537	-3,198 Reduced 5.08%	59,786 $6.5 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $648,773 - $791,137	5,690 Added 9.93%	62,984 $7.46 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $66,314 - $81,198	574 Added 1.01%	57,294 $8.06 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $17,732 - $19,617	152 Added 0.27%	56,720 $6.7 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $1,163 - $1,369	-11 Reduced 0.02%	56,568 $6.56 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $324,452 - $382,253	2,981 Added 5.56%	56,579 $6.78 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $515,235 - $561,458	4,907 Added 10.08%	53,598 $5.87 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $131,595 - $159,812	1,436 Added 3.04%	48,691 $5.3 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $102,833 - $131,614	1,343 Added 2.93%	47,255 $4.32 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $485,787 - $710,353	7,733 Added 20.25%	45,912 $3.62 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $256,570 - $285,623	3,268 Added 9.36%	38,179 $3.32 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $299,861 - $325,143	3,664 Added 11.73%	34,911 $2.92 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $234,017 - $272,935	3,211 Added 11.45%	31,247 $2.63 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $276,667 - $334,490	4,178 Added 17.51%	28,036 $2.24 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $53,562 - $60,678	817 Added 3.55%	23,858 $1.73 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.4 Million - $1.69 Million	23,041 New	23,041 $1.69 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Abbott Laboratories Transaction History